Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection.
Alzheimer Disease
/ diagnosis
Animals
Attention
Brain
/ physiopathology
Brain Mapping
Disease Models, Animal
Electroencephalography
Humans
Interpersonal Relations
Magnetic Resonance Imaging
Memory, Short-Term
Neuropsychological Tests
Research Design
Schizophrenia
/ diagnosis
Schizophrenic Psychology
Social Isolation
Alzheimer’s Disease
IMI
PRISM
schizophrenia
social withdrawal
translation
working memory
Journal
Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
06
11
2017
revised:
29
08
2018
accepted:
27
09
2018
pubmed:
7
11
2018
medline:
30
6
2019
entrez:
7
11
2018
Statut:
ppublish
Résumé
Central nervous system diseases are not currently diagnosed based on knowledge of biological mechanisms underlying their symptoms. Greater understanding may be offered through an agnostic approach to traditional disease categories, where learning more about shared biological mechanisms across conditions could potentially reclassify sub-groups of patients to allow realisation of more effective treatments. This review represents the output of the collaborative group "PRISM", tasked with considering assay choices for assessment of attention and working memory in a transdiagnostic cohort of Alzheimer's disease and schizophrenia patients exhibiting symptomatic spectra of social withdrawal. A multidimensional analysis of this nature has not been previously attempted. Nominated assays (continuous performance test III, attention network test, digit symbol substitution, N-back, complex span, spatial navigation in a virtual environment) reflected a necessary compromise between the need for broad assessment of the neuropsychological constructs in question with several pragmatic criteria: patient burden, compatibility with neurophysiologic measures and availability of preclinical homologues.
Identifiants
pubmed: 30399355
pii: S0149-7634(17)30815-1
doi: 10.1016/j.neubiorev.2018.09.025
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-69Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.